Holta Life Sciences AS, et selskap 100 % eid av Holta Invest AS, har 17.08.2018 solgt 13 800 aksjer i Gentian..
Reference is made to the notice of the Extraordinary General Meeting issued by Gentian Diagnostics AS on 2..
Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 15 June 2018..
An extraordinary general meeting of Gentian Diagnostics AS, reg. no 983 860 516 (the "Company"), will be held..
GENTIAN DIAGNOSTICS AS HAS OBTAINED PROOF OF CONCEPT FOR A NEW PRODUCT FOR EXOCRINE PANCREATIC INSUFICIENCY..
Gentian Diagnostics AS: Directed share issue towards Vatne Equity and Norron